Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report

Here, we report a case of myasthenia gravis and myopathy in a patient treated with nivolumab. A 76‐year‐old man who had been treated with four doses of nivolumab because of non‐small cell lung cancer (NSCLC) presented with proximal‐dominant muscle weakness and fluctuating ptosis and diplopia. Serolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Je‐Seong, Nam, Tai‐Seung, Kim, Jieun, Kho, Bo‐Gun, Park, Cheol‐Kyu, Oh, In‐Jae, Kim, Young‐Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775222/
https://www.ncbi.nlm.nih.gov/pubmed/31436031
http://dx.doi.org/10.1111/1759-7714.13177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775222/
https://www.ncbi.nlm.nih.gov/pubmed/31436031
http://dx.doi.org/10.1111/1759-7714.13177

Ejemplares similares